Stocks Health care SRZN
NASDAQ · Health careSurrozen, Inc. (SRZN)
Surrozen, Inc. brought in $11.5M of revenue over the twelve months to June 30, 2026, down 8.8% from a year earlier. It posted a net loss of $332.1M. In fiscal 2025 capital spending exceeded operating cash flow by $30.4M. At June 30, 2026 it held $102M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Surrozen, Inc. does
Surrozen, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker SRZN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $3.5M | -$242M | -$32.37 | -$30.4M |
| 2024 | $10.7M | -$63.6M | -$21.67 | -$17.7M |
| 2023 | $0 | -$43M | -$21.33 | -$40.8M |
| 2022 | $12.5M | -$36M | -$15.56 | -$44.9M |
| 2021 | $0 | -$54.6M | -$33.07 | -$50.1M |
| 2020 | n/a | -$32.7M | n/a | -$30M |
Where SRZN ranks in Health care
Latest SEC filings
What Surrozen, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 11, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026Delisting notice 25-NSE
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- July 24, 2026Passive stake changed SCHEDULE 13G/A
- May 18, 2026Activist stake changed SCHEDULE 13D/A
- May 15, 2026Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running Surrozen, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Questions about SRZN
What does Surrozen, Inc. do?
Surrozen, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker SRZN.
Is Surrozen, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $332.1M on revenue of $11.5M.
How much revenue does Surrozen, Inc. make?
Over the twelve months to June 30, 2026 Surrozen, Inc. reported revenue of $11.5M. That is 8.8% less than a year earlier.
When did Surrozen, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from August 14, 2026.
Similar companies
Compare SRZN with
Follow SRZN
Get an email when Surrozen, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow SRZN: get an email when it filesWhere the numbers come from
Financial figures are the values Surrozen, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.